Long-Term Survival of Type XVII Collagen Revertant Cells in an Animal Model of Revertant Cell Therapy

    Antoni Gostyński, Sara Llames, Marta García … Marcela Del Río
    Studysummary Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jidonline.org →
    Discuss this study in the Community →

    Research cited in this study 2

    1. First Symposium on Natural Gene Therapy of the Skin Experimental dermatology · 2012
    2. Receptor Activator of NF-κB Stimulates the Proliferation of Epithelial Cells of the Epidermo-Pilosebaceous Unit Proceedings of the National Academy of Sciences of the United States of America · 2011